What is ‘Ozempic personality,’ and why does it make life feel ‘meh’?
In the Washington Post, Dr. Zak Krumm discusses studies into how GLP-1 drugs may affect dopamine signaling and brain reward processing.
In the Washington Post, Dr. Zak Krumm discusses studies into how GLP-1 drugs may affect dopamine signaling and brain reward processing.
The Alzheimer's Research Foundation provided a $100,000 gift to the MBI to support early-career scientists in the field.
MBI researchers demonstrate a next-generation method to peer into tiny molecules in the brain made by metabolism, the chemical processes that break down food, drugs or chemicals.
For more than two decades, Michael Pasternak has worked to help find a cure for trigeminal neuralgia.
UF Center for Advanced Pain Therapeutics and Research (CAPToR) hosts inaugural symposium.
MBRF’s 15th Inter-Institutional Meeting brings together leading scientists working to optimize memory, reasoning and thinking in advancing age.
Neuroscience and neuromedicine at UF ranks No. 2 among all public universities in 2023 NIH funding.
UF neuroscience-neuromedicine community honors MBI past, looks to the future with Luttge Lecture and engaging presentations.
Dr. Jennifer Bizon, named MBI director on Feb. 13, discusses her new role, hopes for the future, research interests and more.
Dr. Sara Burke to co-lead UF’s Center for Cognitive Aging and Memory Clinical Translational Research.